PUTNAM, CT USA - (July 19, 2016) - Foster Corporation, a leader in custom polymers for medical devices, now offers thermoplastic urethanes (TPU) with PureEase™ technology for improved extrusion processing control. This proprietary additive system was developed to help maintain consistent processing parameters of validated TPU based polymers and compounds. Consistent processing parameters can mean tighter ID/OD tubing tolerances especially in small tubes.
PUTNAM, CT USA - (June 16, 2016) - Foster Corporation, a leader in custom polymers for medical devices, introduces a new line of color concentrates using FDA 21CFR 73 subpart D pigments for medical device applications. In support of medical customers in early stages of product development, Foster’s MediBatch™ color concentrates will be available in quantities as low as a single pound.
PUTNAM, CT, USA - (March 8, 2016) - Foster Corporation, a leading supplier of polymer solutions for the healthcare industry, introduces ProFlex™ styrene-ethylene butylene-styrene (SEBS) for medical device applications. These polymers offer a low cost alternative to other thermoplastic elastomers with superior elastomeric properties.
PUTNAM, CT, USA - (January 11, 2016) - Foster Delivery Science, a company that specializes in hot melt extrusion, a solubilization strategy to enhance bioavailability of poorly water soluble drugs, has recently hired Robert Diehl as Director of Quality and Regulatory Compliance. Mr. Diehl has over 30 years of experience in product development and quality control in the pharmaceutical industry.
PUTNAM, CT USA - (September 10, 2015) – Foster Corporation, a leader in custom polymers for medical devices, now offers custom colored medical polymers in quantities as low as 25 pounds (11 kgs) within a two week lead time to support market demand for rapid prototype development. These include formulations using pigments compliant with FDA requirements for use in applications that contact the human body for up to 30 days.
PUTNAM, CT, USA - (July 8, 2015) - Foster Polymer Distribution, a business unit of Foster Corporation specializing in the strategic sourcing of medical polymers and additives, announces the addition of TPX™ polymethylpentene (PMP) to their polymer portfolio. The low surface tension of this olefin copolymer is ideally suited for mandrels used in the manufacturing precision medical tubing and release films for shipping and handling applications. Foster Polymer Distribution will offer TPX™ to the North American medical market.
PUTNAM, CT, USA - (April 7, 2015) - Foster Polymer Distribution, a business unit of Foster Corporation specializing in the distribution of medical polymers and additives, announces their official partnership with Mitsubishi Gas Chemical to distribute MX Nylon to the North American medical market. Mitsubishi’s MX Nylon, a meta-xylene diamine polyamide, offers excellent mechanical and barrier properties for molded components and devices, and medical packaging applications.
PUTNAM, CT, USA - (September 17, 2014) - Foster Delivery Science, a business unit of Foster Corporation and leader in hot melt extrusion (HME) for pharmaceutical and medical device applications, has broken ground on a new facility to support increased demand for manufacturing drug delivery and implant polymer blends.
PUTNAM, CT, USA - (June 5, 2014) - Foster Corporation, a leader in custom polymers for medical devices, introduces LoPro Plus™ radiopaque compounds reinforced with nanoparticles for improved pushability of thin wall catheters. These compounds allow for extrusion of single layer tubes with radiopacity and strength properties equivalent to conventional two layer tubes, in which each layer provides the distinct properties. LoPro Plus reduces material and inventory costs when compared to standard two layer constructions.
PUTNAM, CT, USA - (May 6, 2013) - Foster Corporation, a leader in custom polymers for medical devices, offers LoPro Clear™, a radiopaque polyurethane that is both x-ray visible and optically transparent. Catheters extruded from LoPro Clear™, can be located inside the body using fluoroscopy while fluid flow is visually monitored in the portion outside of the body.